About Us, Without Us: Inclusion in the Threat of Eradication
By Teresa Blankmeyer Burke,
Impact Ethics
| 12. 08. 2015
Untitled Document
The development of CRISPR, a cut-and-paste gene editing technology, has pushed discussions of germline gene “therapy” from speculation about how this might affect us sometime in the future to urgency, leading to the International Summit on Human Gene Editing held this week in Washington DC.
Germline modification of the human genome goes a step beyond what most people think of as genetic therapy, which alters the genome of one individual, to altering the genetic material of that individual and all of that individual’s descendants. If you happen to belong to a community, as I do, that has at its core a group of people with a cluster of genetic variants that contribute to the very nature and existence of said community, this could mean the eradication of a particular population and social community.
I’m speaking of signing Deaf communities, which have developed visual-tactile languages in response to the embodiment of deafness. Signed languages have persisted (despite numerous attempts to extinguish them) in large part because of native use by multi-generational deaf families who have passed this knowledge on...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...